Corbus Pharmaceuticals Holdings (CRBP) Total Liabilities (2013 - 2025)

Corbus Pharmaceuticals Holdings' Total Liabilities history runs 13 years deep, the most recent figure standing at $20.7 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 53.83% year-over-year to $20.7 million; the TTM figure through Dec 2025 stood at $20.7 million (up 53.83% YoY), while the FY2025 annual figure was $20.7 million, up 53.83% from the prior year.
• Total Liabilities was $20.7 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $17.4 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $48.6 million in Q1 2021 to a low of $12.8 million in Q1 2025.
• Historically, Total Liabilities has averaged $29.7 million across 5 years, with a median of $33.0 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities plunged 61.99% in 2024, then surged 53.83% in 2025.
• A 5-year view of Total Liabilities shows it stood at $38.6 million in 2021, then declined by 13.72% to $33.3 million in 2022, then advanced by 5.57% to $35.2 million in 2023, then slumped by 61.76% to $13.5 million in 2024, then jumped by 53.83% to $20.7 million in 2025.
• The last three Total Liabilities figures came in at $20.7 million (Q4 2025), $17.4 million (Q3 2025), and $14.1 million (Q2 2025), per Business Quant data.